Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1055)	2/25/1998 5:23:00 PM
From: Biomaven	Read Replies (1) \| Respond to of 2742

Rick, The swing in shares outstanding is because of the new FAS 128 rules. Because the company had an operating loss for one of the quarters, the options are ignored for that quarter, as they are anti-dilutive (i.e., they would _decrease_ the loss per share by increasing the number of shares outstanding). I've never been a CIST shareholder, but the excess of book value over share price is keeping me looking at it closely. Any chance they might just liquidate it? Peter